USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY
USO DA TOXINA (Português (Brasil))

Keywords

Masseter muscle; Botulinum toxin; Hypertrophy.

How to Cite

Cardoso de Moraes, A. ., Wanderley Interaminense, I. ., Neves Baptista Ferreira, J. ., Portela, E. ., Belém Rodrigues Barros Soares, V. ., & Gomes Moreira, A. . (2021). USE OF BOTULINUM TOXIN TYPE A IN THE TREATMENT OF MASSETER MUSCLE HYPERTROPHY. Advanced Studies on Health and Nature, 1. Retrieved from https://periodicojs.editoraperiodicojs.com.br/index.php/easn/article/view/471

Abstract

Masseter muscle hypertrophy (H.M.M.) is a condition characterized by excessive unilateral or bilateral muscle development in the mandible angle region, which can lead to aesthetic discomfort or functional. The present work aims to describe a clinical case with the use of botulinum toxin type A in the treatment of masseter muscle hypertrophy. Patient E.A.A.P.F., male, 32 years old, attended the Specialization clinic in Orofacial Harmonization at ESPEO (Pernambucana School of Dentistry) complaining of pain in the region of the masseter muscle. The proposed treatment was the application of botulinum toxin type A. In the first session, the toxin was applied in 3 points of the masseter muscle with 10 U each (30 U on each side), which gave a significant improvement to the pain picture. After 4 months, a second toxin application was made with 28U of Xeomin© on each side (distributed in 3 points in 10U, 10U and 8U). Six months after the last application, the patient presented sporadic pain and use of muscle relaxant at specific moments. Therefore, it was concluded that the application of TX A for masseter muscle hypertrophy is a more conservative treatment compared to the surgical procedure. It is an alternative treatment to reduce or eliminate drugs, but it is temporary and also. This application to toxin, associated with other techniques and treatments, enhances and improves the quality of life of patients, acting both in terms of aesthetics and functionality.

USO DA TOXINA (Português (Brasil))

References

ACOSTA, R.T.; KELMER, F. Uso da toxina botulínica como efeito terapêutico para tratamento de assimetria facial causada por hipertrofia do Músculo Masseter. Rev. Uningá. Maringá, v.21, n.1, p. 24-26, jan./março, 2015.

ALVES, C.C.B.; CAVALCANTI, N.B.G.; HOFFMAN, L.E. O uso das toxinas botulínicas no tratamento da hipertrofia do masseter – Revisão integrativa. Rev.Simetria, São José dos Pinhais, v.1, n.1, p.96-101, 2019.

ALTAMIRO, F. Casos Clínicos. In: Toxina botulínica para Harmonização Facial. São Paulo: Natoleão Quitessence. ,p.156-162, 2019.

BAS, B.0.C.; MUGLALI, M.; CELEBI, N. Treatment of masseter hypertrophy with botulinum toxin: A report of two cases. Med. Oral Patol. Oral Cir. Bucal. v.15, n.4, p.649-52, jul., 2010.

BRAVO, B. S. F.; BALASSIANO, L.K. Thinning of the lower third of the face using botulinum toxin in the masseter muscle. Surg. Cosmet. Dermat. v.8, n.1, p.55-60, 2016.

CELÓRIA, A. Harmonização Funcional Orofacial. São Paulo: Napoleão, 2019.

COSTA, E.T.; NASCIMENTO, L.A.O.; FERNANDES, K.J.M. Toxina botulínica no tratamento de disfunção temporomandibular miofascial: Revisão de literatura. Rev. ACBO. v. 27, n.1, p.96-102, 2018.


FASSINA, M.T. et. al. Toxina botulínica tipo A nas D.T.M musculares: Há eficácia? Rev. Odonto. v.24, n.48, p.1-13, 2016.

KIM, S.T.; CHOI, Y.M. Effect of botulinum toxin type A injection in to human masseter muscle on stimulated parotid saliva flow rate. Internacional Journal of Oral e Maxillofacial Surgery, v.38, p. 316-20, 2009.

KIM, M.D. et. al. Botulinum toxin type A for the treatment of hyperthophy of the Masseter muscle. Plastic. And Reconstructive Surgery, v. 125, n.6, p.1693-1705, 2009.

KLEIN, F.H.M.S. et.al. Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy. An. Bras. Dermatol., Curitiba, v.89, n.5, p. 878-84, 2014.

MANDEL, D.D.S.; THARAKAN, M. Treatment of Unilateral Masseteric hypertrophy with botulinum toxin: Case Report. J. Oral Maxillofac. Surg. v.57, p.1017-19, 1999.

MOHAMMED, A.A. et. al. Botulinum toxin for masseter hypertrophy. Cochrane Database of Systematic Review, 2009.

PEREIRA, A.J.A. JÚNIOR; CARVALHO, P.A.G. Tratamento da hipertrofia muscular mastigatória com toxina botulínica tipo A. HU Revista, Juiz de Fora, v.35, n.4, p.315-319, out./dez., 2009.

PETROLLI, G.O.P. et. al. Tratamento de disfunções temporomandibulares com toxina botulínica tipo A. Rev. F.O. U.P.F., Passo Fundo, v.23, n.2, p.236-241, maio/ago., 2018.

SANNOMIYA, E.K.; GONÇALVES, M.; CAVALCANTI, M.P. Masseter Muscle hypertrophy – Case Report. Braz. Dent. J., São Paulo, v.17, n.4, p.347-350, 2006.

SMYTH, A.G. Botulinum toxin treatment of bilateral masseteric hypertrophy. British Journal of Oral and Maxillofacial Surgery, v.32, p.29-33, 1994.

SOUZA, L.CLM. et al. Hipertrofia do Músculo Masseter. Rev. Bras. Cir. Plast., São Paulo, v. 15, n.1, p.45-54, jan./abr., 2000.

VON LINDERN, J.J. et. al. Type A Botulinum toxin for the Treatment of Hypertrophy of the Masseter and temporal Muscles: Na Alternative treatment. Plastic and Reconstructive Surgery, v. 107, p.327-332, 2001.

XIE, Y. et. al. Classification of masseter hypertrophy for tailored botulinum toxin typer A treatment. Plast. Reconstr. Surg., v.134, p. 2009-2014, 2014.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...